Astria Therapeutics
Why Robinhood?
You can watch ATXS and buy or sell other stocks, ETFs, and their options commission-free!About ATXS
Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway.
ATXS Key Statistics
Stock Snapshot
As of today, Astria Therapeutics(ATXS) shares are valued at $12.58. The company's market cap stands at 709.95M, with a P/E ratio of -5.85.
On 2026-03-10, Astria Therapeutics(ATXS) stock opened at —, reached a high of —, and a low of —.
The Astria Therapeutics(ATXS)'s current trading volume is 0, compared to an average daily volume of 581.79K.
In the last year, Astria Therapeutics(ATXS) shares hit a 52-week high of $13.29 and a 52-week low of $3.56.
In the last year, Astria Therapeutics(ATXS) shares hit a 52-week high of $13.29 and a 52-week low of $3.56.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.